Skip to content
Screener

Bausch Health Companies BHC Total costs & expenses

Total costs & expenses at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$1.31B+1.7%
Ardelyx logo
ArdelyxARDX
$133.3M+19.0%
Ironwood Pharmaceuticals logo
Ironwood PharmaceuticalsIRWD
$33.73M-15.5%
Journey Medical Corporation logo
Journey Medical CorporationDERM
$17.45M+6.0%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$3.33M-5.0%
AbbVie logo
AbbVieABBV

Other financials

Income statement

See full
Revenue$2.5B+11.7%
Operating income-$950.0M-444%
Net income-$1.4B-2,353%
EPS (diluted)-$3.82-2,287%

Balance sheet

See full
Cash & equivalents$1.3B+13.4%
Total debt$20.8B-3.5%
Total equity-$2.1B-74.0%
Total assets$24.5B-7.3%

Cash flow

See full
Operating cash flow$230.0M+9.0%
CapEx$109.0M-5.2%
Free cash flow$121.0M+26.0%

Valuation

See full
Market cap$2.37B+11.7%
Enterprise value$21.83B-1.3%
P/S0.2×0.0×

Profitability

See full
Gross margin71.4%
Operating margin5.6%-10.3pp
Net margin-1.9%-0.9pp
FCF margin9.8%-2.8pp

Returns & leverage

See full
Return on equity-70.1%
Debt / equity45.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:CostsAndExpenses.

The source filing: Bausch Health Companies’s 10-Q, filed April 30, 2026.

Filed
Apr 29, 2026, 6:12 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000885590-26-000053
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Goodwill impairments1,426
Restructuring, integration and separation costs131
Other expense, net3215
3,4741,983
Operating (loss) income(950)276
Interest income1011
Interest expense(402)(330)
Loss on extinguishment of debt(1)

Item 1. Condensed Consolidated Financial Statements (unaudited)

FAQ

What is Bausch Health Companies's total costs & expenses?
Bausch Health Companies (BHC) reported total costs & expenses of $3.47B in Q1 2026.
How has Bausch Health Companies's total costs & expenses changed year-over-year?
Bausch Health Companies's total costs & expenses increased by 75.2% year-over-year, from $1.98B to $3.47B.
What is the long-term trend for Bausch Health Companies's total costs & expenses?
Over 4 years (2021 to 2025), Bausch Health Companies's total costs & expenses has grown at a 1.4% compound annual growth rate (CAGR), from $7.98B to $8.45B.
What does total costs & expenses mean?
This represents the aggregate of all operating and non-operating costs incurred by the company to generate revenue, including cost of goods sold, research and development, and selling, general, and administrative expenses. It provides a comprehensive view of the total resource consumption required to sustain business operations. Monitoring this metric relative to revenue growth is essential for evaluating overall operational efficiency and margin sustainability.

Ask your AI about Bausch Health Companies's total costs & expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude